Polysomnography
OtherAn overnight sleep study
Other names: Biology (urine, blood, faeces), Questionnaries, electromyogram, electroencephalogram
NCT Number: NCT06582121
Multicenter controlled study of sleep disorders in isolated REM Behavior Disorder and Parkinson's disease (SOMPARK)
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
CHU de Clermont-Ferrand, Clermont-Ferrand, France
Sleep disturbances are common and understudied in established or prodromal Parkinson's disease. The purpose of this study is to systematically and comprehensively determine the clinical characteristics and electrophysiologic patterns of the major sleep disorders in PD and isolated RBD.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Common to all groups:
For Parkinson Disease (PD):
For REM Sleep Behavior Disorder (RBD):
For healthy controls:
Exclusion criteria
Common to all groups:
An overnight sleep study
Other names: Biology (urine, blood, faeces), Questionnaries, electromyogram, electroencephalogram
Time frame: 25 months
Using polysomnography to compare sleep efficiency in the 3 study populations during the first night
Contact information is provided by the study sponsor or research team.
Assistance Publique - Hôpitaux de Paris
Other
Controlled, Multicenter Study of Sleep Disorders in Prodromal and Definite Parkinsons Disease
Acronym: SOMPARK
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07355842
Basal Ganglia Diseases, Brain Diseases
Zurich, Canton of Zurich, Switzerland
View Trial DetailsNCT05205291
Basal Ganglia Diseases, Brain Diseases
Exeter, United Kingdom
View Trial DetailsNCT01799915
Autonomic Nervous System Diseases, Basal Ganglia Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT06329453
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
North Haven, Connecticut, United States
View Trial Details